IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for COVID-19
![](https://images.financialexpress.com/2020/09/covid-vaccine1.jpg)
The agreement is "to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research as innovative interventions to address the COVID-19 pandemic", the partners said in a statement on Thursday.
from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...
No comments: